Injectable Drug Delivery Market Size to Reach USD 1,345.05 Billion in 2028 – Reports and Data

Rising prevalence of chronic diseases such as diabetes and cancer, coupled with advancements in drug delivery methods, is expected to drive market growth

The global injectable drug delivery market size is expected to reach USD 1,345.05 billion by 2028 at a CAGR of 11.3%, according to a new report by Reports and Data. Market revenue growth is majorly driven by rising prevalence of chronic diseases such as diabetes, cancer, and various autoimmune diseases, development of advanced biologics, technological innovations in injectable device design, and rising adoption of injectable drug delivery systems due to several advantages such as ease of use, lesser pain, and enhanced safety. Increasing use of self-injectable devices due to several benefits such as convenient use, cost-effectiveness, and high-precision drug delivery is another major factor accountable for the global market growth.

Injectable drug delivery refers to intravenous or subcutaneous administration of drugs and uses injectable devices for drug delivery. The injectable method is one of the most effective drug delivery methods and is most suitable for drugs that have poor oral bioavailability. This drug delivery method is most widely used for conditions including hormonal imbalance, autoimmune diseases, cystic fibrosis, hemophilia, Wilson’s disease, and hepatitis C. Over the years, the development of self-injection devices such as pen-injectors, auto-injectors, and needle-free injectors, has made it quite easy for patients to administer drugs at home without any professional assistance. Furthermore, emerging drug delivery technologies such as dual-injectables are rapidly gaining traction globally, with the growing need for advanced patient care.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1382

Some Key Highlights in the Report:

• Based on type, the formulation segment is expected to reach the largest market share over the forecast period. Growing use of colloidal dispersions, lyophilized formulations, solutions, and suspensions in drug delivery systems and increasing research & development activities for advanced formulations are key factors boosting the growth of this segment.  
• The self-injectable devices sub-segment is expected to display robust growth in revenue in the coming years, owing to surging adoption of self-injectable devices such as auto-injectors, needle-free injectors, and pen injectors and several advantages of their use.
• Based on end-use, the hospitals segment is expected to register the highest CAGR of 11.3% over the forecast period. Rising prevalence of chronic diseases such as cancer and diabetes, increasing hospital admissions, and extensive use of advanced injectable drug delivery systems are the major factors boosting this segment’s growth.
• North America is the leading regional market in the global injectable drug delivery market in terms of revenue. Rising burden of chronic and infectious diseases, increasing use of advanced biologics, growing adoption of self-injectable devices, and increasing focus on patient comfort and safety are the key factors contributing to the North America market growth.
• The leading market competitors include Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.
• In December 2020, Caplin Point Laboratories’ subsidiary Caplin Steriles received the U.S. FDA approval for its Etomidate injection USP. Reportedly, the company received a nod from the U.S. drug regulator for its abbreviated new drug application (ANDA) for the etomidate injection USP 20 mg/10 ml and 40 mg/20 ml.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1382

For the purpose of this report, the global injectable drug delivery market is segmented on the basis of type, application, end-use, and region:

Type Outlook (Revenue, USD Billion; 2018-2028)

• Formulation

• Conventional drug delivery (solutions, reconstituted/ lyophilized formulations, suspensions)
• Novel drug delivery (colloidal dispersions and nanoparticles)
• Others

• Devices

• Self-injectable devices (auto-injectors, needle-free injectors, pen injectors, and others)
• Conventional injection devices

Application Outlook (Revenue, USD Billion; 2018-2028)

• Hormonal Disorders
• Autoimmune Diseases
• Oncology Disorders
• Orphan Diseases
• Diabetes
• Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

• Hospitals
• Clinics
• Ambulatory Care Centers
• Home Care Centers
• Clinical and Diagnostic Laboratories
• Research Institutes
• Others

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1382

Regional Outlook (Revenue, USD Billion; 2018-2028)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of the Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Rest of the Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Alpha-Adrenoreceptor Antagonists Market Size, Share & Analysis, By Product Type (Oral, Injection), By Application (Hospital, Clinic), By Region, Forecast To 2027

Serotonin Antagonists Market Size, Growth & Analysis, By Type (Tablet, Injectable, Syrup), By End-Use (Hospital, Clinic), By Region Forecast To 2027

Protein Kinase Inhibitors Market Size, Demand & Analysis, By Type (Serine/ Threonine, Tyrosine, Histidine), By Therapy (Monotherapy, Combination Therapy), By Drug Class (Phorbol Esters, Indolocarbazole, Macrocyclic Lactones, Nonsteroidal Anti-Oestrogen, Others), By Route Of Administration (Intravenous, Oral, Others), By Region, Forecast To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-injectable-drug-delivery-market